Haemonetics (HAE) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 27, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 3 added, 1 cutMore adding
Federal contractsUSAspending.gov, last 12 months: 10+ awardsAwards on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about HAE filings

Are insiders buying or selling Haemonetics Corporation (HAE) stock?

Neither. Haemonetics Corporation (HAE) insiders filed no open-market purchases or sales in the 90 days to Oct 27, 2026, according to SEC Form 4 filings.

Which members of Congress have traded HAE recently?

None. No member of Congress disclosed a HAE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HAE smart-money data?

This summary uses filings available on Oct 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on HAE

Lean long1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
No recent politician filings found
Funds
Lean long3 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about HAE filings

Are insiders buying or selling Haemonetics Corporation (HAE) stock?

Neither. Haemonetics Corporation (HAE) insiders filed no open-market purchases or sales in the 90 days to Oct 27, 2026, according to SEC Form 4 filings.

Which members of Congress have traded HAE recently?

None. No member of Congress disclosed a HAE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HAE smart-money data?

Funds

What funds are doing

6 moves · 6 mo

Buys/Adds$295.5MSells/Trims$204.2M

Buys/Adds (3)

AI
Ariel Investments
Q2 2026 13F
$154.6M
bought
Signals like this: n=3224, 54% finished lower at D15, median -0.8% vs SPY -0.4%
CI
Citadel
Ken Griffin · Q2 2026 13F
$98.7M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
MI
Millennium
Israel Englander · Q2 2026 13F
$42.2M
added

3 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 3 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 6, 2026

Earnings came in 5.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 27, 2026

Earnings per share

$1.14+5.85% beat

$1.08 expected

Revenue

$339.4M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Period ending	Reported	EPS / estimate	EPS surprise	Revenue / income	Surprise
Jun 27, 2026	Aug 6, 2026	$1.14 / $1.08Yahoo Finance	+5.85% beat	$339.4M No estimateSEC filing	Unavailable
Mar 31, 2026	May 7, 2026	$1.29 / $1.27Yahoo Finance	+1.38% beat	$346.4M No estimate	Unavailable
Dec 27, 2025	Feb 5, 2026	$1.31 / $1.25Yahoo Finance	+4.77% beat	$339.0M No estimateSEC filing	Unavailable
Sep 27, 2025	Nov 6, 2025	$1.27 / $1.11Yahoo Finance	+14.35% beat	$327.3M No estimateSEC filing	Unavailable
Jun 28, 2025	Aug 7, 2025	$1.10 / $1.01Alpha Vantage	+8.91% beat	$321.4M No estimateSEC filing	Unavailable
Mar 31, 2025	May 8, 2025	$1.24 / $1.22Alpha Vantage	+1.64% beat	$1.36B No estimateYear ended Mar 29, 2025 · SEC filing	Unavailable
Dec 28, 2024	Feb 6, 2025	$1.19 / $1.17Alpha Vantage	+1.71% beat	$348.5M No estimateSEC filing	Unavailable
Sep 28, 2024	Nov 7, 2024	$1.12 / $1.07Alpha Vantage	+4.67% beat	$345.5M No estimateSEC filing	Unavailable

EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.

Open: $115.50
52-wk high: $123.77
High: $119.20
52-wk low: $48.98
Low: $115.49
Prev close: $116.16
Mkt cap: $5.39B
P/E: 57.3x
ROE: +11.2%
Fwd P/E: 10.0x
Beta: 0.61
P/S: 4.0x
P/B: 2.7x
Profit margin: +7.1%
Op margin: +17.9%

Fundamentals

Is the business strong?

Richly priced and running thin margins.

Net margin: 7.1%
P/E: 57.25
Forward P/E: 10.04
Market cap: $5.4B

Valuation

P/S3.99
P/B2.67

Quality

Operating margin17.9%
ROE11.2%
ROA6.6%

Growth

Beta0.61

Technicals

Price structure

This stock is in a strong uptrend, and looks overbought after a fast run-up.

Trend

Strong uptrend

85 / 100

RSI 14

70overbought

20D volatility

61%annualized

52-week range

$118.51

$48.98$123.77

20D support

$101.31recent floor

20D resistance

$123.77recent ceiling

Returns

5D +0.2%20D +12.5%60D +39.7%

Price vs moving averages

SMA20 +4.5%SMA50 +9.6%SMA200 +52.6%

Volume pace

1.21xvs prior 20D

Period ending

Reported

EPS / estimate

EPS surprise

Revenue / income

Surprise

Jun 27, 2026

Aug 6, 2026

$1.14 / $1.08Yahoo Finance

+5.85% beat

$339.4M No estimateSEC filing

Unavailable

Mar 31, 2026

May 7, 2026

$1.29 / $1.27Yahoo Finance

+1.38% beat

$346.4M No estimate

Unavailable

Dec 27, 2025

Feb 5, 2026

$1.31 / $1.25Yahoo Finance

+4.77% beat

$339.0M No estimateSEC filing

Unavailable

Sep 27, 2025

Nov 6, 2025

$1.27 / $1.11Yahoo Finance

+14.35% beat

$327.3M No estimateSEC filing

Unavailable

Jun 28, 2025

Aug 7, 2025

$1.10 / $1.01Alpha Vantage

+8.91% beat

$321.4M No estimateSEC filing

Unavailable

Mar 31, 2025

May 8, 2025

$1.24 / $1.22Alpha Vantage

+1.64% beat

$1.36B No estimateYear ended Mar 29, 2025 · SEC filing

Unavailable

Dec 28, 2024

Feb 6, 2025

$1.19 / $1.17Alpha Vantage

+1.71% beat

$348.5M No estimateSEC filing

Unavailable

Sep 28, 2024

Nov 7, 2024

$1.12 / $1.07Alpha Vantage

+4.67% beat

$345.5M No estimateSEC filing

Unavailable

Haemonetics Corporation

Smart money at a glance

What do analysts expect?

Questions about HAE filings

Smart money on HAE

Questions about HAE filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 5.8% above what analysts expected.

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Is the business strong?

Price structure

Haemonetics Corporation

Smart money at a glance

What do analysts expect?

Questions about HAE filings

Smart money on HAE

Questions about HAE filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 5.8% above what analysts expected.

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Is the business strong?

Price structure

Haemonetics Corporation

Overview

Questions about HAE filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Haemonetics Corporation

Overview

Questions about HAE filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals